South China Morning Post World
China’s Biotech Boom Spurs US Strategic Concerns and Regulatory Scrutiny
China’s record-breaking biotech out-licensing deals have raised alarms in the US, prompting new legislation and heightened scrutiny over pharmaceutical supply chains and technological leadership.